| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |